Clinical Trial Update: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update on PD-1 inhibitor in combination with chemotherapy as adjuvant treatment for gastric cancer, with the study currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Gastric or Esophagogastric Junction Adenocarcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING